Prescription pattern of fixed dose drug combination in cardiology department in a tertiary care hospital
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20161550Keywords:
FDCs, Cardiovascular disordersAbstract
Background: A cardiovascular disease (CVD) is one of the most common causes of mortality and morbidity globally. The drastic change in the lifestyle of population during 21st century has had a great impact on health especially cardiovascular diseases. Objective of this study was to assess the prescription pattern of fixed dose drug combinations (FDCs) in the department of cardiology in a tertiary care hospital.
Methods: The prescriptions of 210 patients suffered by cardiovascular disorders who attended the department of cardiology were analysed and following data were collected - patient demographics, diagnosis, dosage form, therapeutic category, cost of FDCs compared to individual drugs, duration of therapy, the total number of drugs per prescription and FDCs prescribed, composition of the FDC, whether FDC prescribed is approved by WHO list of essential medicine. A descriptive analysis of data was done.
Results: 15 types of FDCs prescribed were received by 92(43.80%) individuals among 210 patients who attended the cardiology OPD. Prescription of FDCs was most common 28 (30.43%) in patients age group 51-60 years. The commonly prescribed FDC was aspirin with atorvastatin followed by telmisartan with hydrochlorothiazide.
Conclusions: The results suggested that FDCs for cardiovascular disorders are frequently prescribed by cardiologist. However all are not approved by WHO list of essential medicine. This study was focused on rational use of FDCs for prescribers for cardiovascular morbidities and mortality.
References
World health statistics 2009. Table 2: cause-specific mortality and morbidity. Available at http://www.who.int/whosis/whostat/EN_WHS09_ Table2.pdf. Accessed 2 July 2010.
Ara S. A literature review of cardiovascular disease management programs in managed care populations. J Manag Care Pharm. 2004;10:326-44.
Ford EA, Ajani UA, Croft JB, Critchley, JaLabarthe DR, KottkeTE, et al. Explaining the decline in coronary mortalityin the United States between 1980 and 2000. N Engl J Med. 2007;356:2388-98.
WHO, Model list of essential medicines 19th list. Available at http://www.who.int/medicines/publications/essentialmedicines/en/.
Mohanty BK, Aswini M, Hasamnis AA. Prescription pattern in the department of medicine of a tertiary care hospital in South India. J Clin Diagnostic Res. 2010;4:2047-51.
Bhansali NB, Gosai TR, Dholaria NK. Drug utilization study in post-operative patients in surgical ward of a tertiary hospital attached with medical college. Der Pharmacia Lettre. 2013;5(1):251-7.
Ranjeeta K, Idris MZ, Vidya B, Anish K, Monika A, Shivendra KS. Assessment of prescription pattern at the public health facilities of Lucknow district. Indian J Pharmacol. 2008;40:243-7.
Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326(7404):1419.
Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120(8):713-9.
Gerbino PP, Shoheiber O. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. Am J Health Syst Pharm. 2007;64(12):1279-83.
Combination pharmacotherapy and public health research working group. Combination pharmacotherapy for cardiovascular disease. Ann Intern Med. 2005;143(8):593-9.
Young CL, Dias VC, Stangier
J. Multiple-dose pharmacokinetics of telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects. J Clin Pharmacol. 2000;40:1323-30.
Vijayakumar TM, Poovi G, Swaroop TVSS, Thirumurugan G, Dhanaraju MD. Prescribing pattern of fixed dose combinations: focus on cardiovascular drugs in outpatient department of private hospitals. Journal of pharmacology and toxicology., 2010;5(5)215-21.
Sharif SI, Shaqra M, Hajjar H. Shamout L. Wess. patterns of drug prescribing in a hospital in dubai, United Arab Emirates. Libyan J Med. 2007;3.
Rozenfeld S, Fonseca MJ, Acurcio FA. Drug utilization and poly pharmacy among the elderly: a survey in Rio de Janeiro City, Brazil. Rev Panam Salud Publica. 2008;23:34-43.
KD Tripathi. Aspects of pharmacotherapy, clinical pharmacology and drug development. Essentials of medical pharmacology. 7th ed. New Delhi: Jaypee; 2013:61-62.
